Volume 18, Issue 1, Pages (July 2013)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 5, Pages (November 2011)
Advertisements

Volume 14, Issue 2, Pages (August 2011)
Volume 18, Issue 1, Pages (July 2013)
Volume 20, Issue 5, Pages (November 2014)
Volume 20, Issue 3, Pages (July 2017)
Volume 15, Issue 1, Pages (January 2012)
TFE3 regulates glucose homeostasis
Volume 20, Issue 4, Pages (October 2014)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 8, Issue 5, Pages (November 2008)
Volume 6, Issue 3, Pages (September 2007)
Volume 18, Issue 2, Pages (August 2013)
Volume 18, Issue 1, Pages (July 2013)
Volume 6, Issue 3, Pages (September 2007)
Volume 11, Issue 4, Pages (April 2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 29, Issue 4, Pages (April 2016)
Volume 15, Issue 5, Pages (May 2012)
Volume 15, Issue 5, Pages (May 2012)
Volume 25, Issue 2, Pages (February 2017)
Volume 18, Issue 6, Pages (December 2013)
Volume 25, Issue 2, Pages e4 (October 2018)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Volume 12, Issue 5, Pages (November 2010)
Volume 7, Issue 4, Pages (May 2014)
Volume 10, Issue 1, Pages (July 2009)
Volume 14, Issue 2, Pages (August 2011)
Volume 20, Issue 1, Pages (July 2014)
Volume 9, Issue 3, Pages (March 2009)
Volume 16, Issue 7, Pages (August 2016)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 23, Issue 6, Pages (June 2016)
Volume 137, Issue 4, Pages (May 2009)
Volume 10, Issue 5, Pages (November 2009)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 14, Issue 1, Pages (July 2011)
Volume 21, Issue 5, Pages (May 2015)
Volume 5, Issue 5, Pages (May 2007)
Volume 24, Issue 8, Pages e7 (August 2018)
Volume 6, Issue 1, Pages (July 2007)
Volume 6, Issue 3, Pages (September 2007)
Volume 14, Issue 4, Pages (October 2011)
Volume 14, Issue 5, Pages (November 2011)
Prevention of Steatosis by Hepatic JNK1
Volume 15, Issue 6, Pages (June 2012)
Volume 8, Issue 1, Pages (July 2008)
Volume 12, Issue 6, Pages (December 2010)
A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 14, Issue 2, Pages (August 2011)
Volume 14, Issue 6, Pages (December 2011)
Volume 7, Issue 6, Pages (June 2008)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 6, Issue 4, Pages (October 2007)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Volume 2, Issue 2, Pages (August 2005)
Volume 1, Issue 5, Pages (May 2005)
Of Mice and Men: Not ExAKTly the Same?
Volume 26, Issue 2, Pages e3 (January 2019)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Volume 16, Issue 3, Pages (September 2012)
Regulation of Gluconeogenesis by Krüppel-like Factor 15
Presentation transcript:

Volume 18, Issue 1, Pages 99-105 (July 2013) A Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen Deposition  Min Wan, Karla F. Leavens, Roger W. Hunter, Shlomit Koren, Alexander von Wilamowitz-Moellendorff, Mingjian Lu, Santhosh Satapati, Qingwei Chu, Kei Sakamoto, Shawn C. Burgess, Morris J. Birnbaum  Cell Metabolism  Volume 18, Issue 1, Pages 99-105 (July 2013) DOI: 10.1016/j.cmet.2013.06.001 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Deletion of Akt2 in the Liver Results in Hepatic Insulin Resistance (A) Chow-fed 2-month-old male control (Akt2(lox/lox)) and liver-specific Akt2 KO (Akt2(lox/lox); AFP > CRE) mice were subjected to a euglycemic-hyperinsulinemic clamp. GIR, glucose infusion rate; HGP, hepatic glucose production; Rd, rate of glucose disposal. Data are expressed as mean ± SEM; n = 4 for each genotype; ∗p < 0.05; ∗∗p < 0.01 by Student’s t test. (B) Glucose infusion rates during the euglycemic-hyperinsulinemic clamp. 2- to 3-month-old male control (Akt2(lox/lox)) and liver-specific Akt2 KO (Akt2(lox/lox); AFP > CRE) mice were subjected to a euglycemic clamp with infusion of insulin at 2.5 mU/kg/min. See also Figure S1. (C) G6pc and Pck1 mRNA levels in the liver at the termination of the clamp. (D) Hepatic glycogen content after the termination of the clamp. Data are expressed as mean ± SEM; n = 5–7 for each condition; ∗p < 0.05; ∗∗p < 0.01 by two-way ANOVA followed by the Bonferroni post hoc test. Cell Metabolism 2013 18, 99-105DOI: (10.1016/j.cmet.2013.06.001) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Postprandial Hepatic Glycogen Accumulation Is Blunted in the Akt2(lox/lox); AFP > CRE Mice (A) Livers from control and Akt2 KO mice were perfused ex vivo, and glucose production, glycogenolysis, and gluconeogenesis was measured by isotopomer analysis of incorporated deuterium. Data are expressed as mean ± SEM; n = 4–6 for each condition; ∗p < 0.05; ∗∗p < 0.01 by two-way ANOVA followed by the Bonferroni post hoc test. (B–D) Male control (Akt2(lox/lox)) and liver-specific Akt2 KO (Akt2(lox/lox); AFP > CRE) mice (2 months old) were fasted overnight, refed, and, at 1 and 4 hr, assayed for (B) blood glucose and serum insulin, (C) gene expression, and (D) hepatic glycogen (left, 1 hr refed; right, 4 hr refed). Data are expressed as mean ± SEM, n = 5–7; ∗p < 0.05; ∗∗p < 0.01 by two-way ANOVA followed by the Bonferroni post hoc test. See also Figures S2D and S2E. Cell Metabolism 2013 18, 99-105DOI: (10.1016/j.cmet.2013.06.001) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 GSK3 Phosphorylation Is Not Required for Insulin-Dependent Accumulation of Glycogen in Liver (A and B) Immunoblot for phosphorylated Akt and GSK3α and GSK3β in livers from fasting mice at 1 hr (A) or 4 hr (B) after refeeding (upper panels). Quantification of Akt and GSK3 phosphorylation is shown in lower panels. (C) Hepatic glycogen content at the termination of the clamp. Male control or GSK3αS21A/S21A;βS9A/S9A mice (3 months old) were infused with PBS or insulin at 10 mU/kg/min while glucose was clamped as in Figure 2. Data are expressed as mean ± SEM; n = 6–7 for each condition; ∗p < 0.05 by two-way ANOVA followed by the Bonferroni post hoc test. See also Figure S3. (D–F) GSK3αS21A/S21A;βS9A/S9A mice and their controls were fasted overnight followed by 1 hr refed. (D) Blood glucose levels, (E) serum insulin levels, and (F) hepatic glycogen content were assayed at fasting and refeeding. n = 5 for each condition. Data are expressed as mean ± SEM; ∗∗p < 0.01 by two-way ANOVA followed by the Bonferroni post hoc test. See also Figures S2A–S2C. Cell Metabolism 2013 18, 99-105DOI: (10.1016/j.cmet.2013.06.001) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Glycogen Synthase Activity Is Blunted after Refeeding in the Akt2(lox/lox); AFP > CRE Mice (A) Immunoblot for phosphorylated glycogen synthase (GS) and glycogen phosphorylase (GP) in livers from fasting mice and 1 hr after refeeding. (B) Hepatic GS activity after 1 hr refeeding. Data are expressed as mean ± SEM; ∗∗p < 0.01 by two-way ANOVA followed by the Bonferroni post hoc test. See also Figure S4. Cell Metabolism 2013 18, 99-105DOI: (10.1016/j.cmet.2013.06.001) Copyright © 2013 Elsevier Inc. Terms and Conditions